NCT03162224 2022-08-25Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck CancerMedImmune LLCPhase 1/2 Completed35 enrolled 25 charts